Anjali Ganguli is currently the Vice President of Corporate Development at Syndax Pharmaceuticals NYC. At Syndax, Anjali leads business development, investor relations, alliance management, and pre-commercial efforts. Anjali has spent over 12 years facilitating health care businesses through both research and consulting. She earned a B.S. at the University of Chicago, a Ph.D. in Medicinal Chemistry from the University of Michigan, and conducted her post-doctoral research in biochemistry at the University of California Berkeley.